🇺🇸 FDA
Patent

US 7476657

Peptides and peptidomimetics having anti-proliferative activity and/or that augment nucleic acid damaging agents or treatments

granted A61KA61K38/00A61K47/62

Quick answer

US patent 7476657 (Peptides and peptidomimetics having anti-proliferative activity and/or that augment nucleic acid damaging agents or treatments) held by Takeda Pharmaceutical Company Limited expires Mon Jan 08 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Jan 13 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 08 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K38/00, A61K47/62, A61K47/64, A61K51/088